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proteins including PSD95/93 (Brenman et al., 1996) and
CAPON (Jaffrey et al., 1998). These interactions are
thought to facilitate the targeting of nNOS to distinct
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NO signals within cells through posttranslational co-and Molecular Sciences, and Psychiatry
School of Medicine valent modification of proteins. The most studied exam-
ple is the binding of NO to heme in soluble guanylylThe Johns Hopkins University
Baltimore, Maryland 21205 cyclase, leading to activation of the enzyme and in-
creased formation of cGMP (Denninger and Marletta,
1999). NO can also directly modify cysteine residues in
proteins, leading to the formation of a nitrosothiol ad-Summary
duct (Stamler et al., 1997). The ability of endogenous
NO to diffuse to various targets within the cell may beBecause nitric oxide (NO) is a highly reactive signal-
compromised by the high concentrations of glutathioneing molecule, chemical inactivation by reaction with
and other molecules that can degrade NO. Accordingly,oxygen, superoxide, and glutathione competes with
one might anticipate that physiologic targets of NOspecific interactions with target proteins. NO signaling
should be closely juxtaposed to NOS, with the juxtaposi-may be enhanced by adaptor proteins that couple
tion established by appropriate targeting proteins. In aneuronal NO synthase (nNOS) to specific target pro-
search for such targeting proteins, we identified CAPON,teins. Here we identify a selective interaction of the
a 55 kDa protein that contains a C-terminal domain thatnNOS adaptor protein CAPON with Dexras1, a brain-
binds to the PDZ domain of nNOS, as well as anenriched member of the Ras family of small mono-
N-terminal phosphotyrosine binding (PTB) domain (Jaf-meric G proteins. We find that Dexras1 is activated by
frey et al., 1998).NO donors as well as by NMDA receptor–stimulated
We sought to determine whether CAPON targetsNO synthesis in cortical neurons. The importance of
nNOS within the cell. In the present study, we identifyDexras1 as a physiologic target of nNOS is established
a selective interaction of CAPON with Dexras1, a brain-by the selective decrease of Dexras1 activation, but
enriched member of the Ras family of small monomericnot H-Ras or four other Ras family members, in the
G proteins that was recently identified in a screen forbrains of mice harboring a targeted genomic deletion
genes induced by dexamethasone (Kemppainen andof nNOS (nNOS2/2). We also find that nNOS, CAPON,
Behrend, 1998). We find that Dexras1, like H-Ras, isand Dexras1 form a ternary complex that enhances
S-nitrosylated by NO donors and is activated by NOthe ability of nNOS to activate Dexras1. These findings
donors and by coexpression with nNOS. The importanceidentify Dexras1 as a novel physiologic NO effector
of Dexras1 as a physiologic target of nNOS is estab-and suggest that anchoring of nNOS to specific targets
lished by its activation by NMDA receptor–stimulatedis a mechanism by which NO signaling is enhanced.
nNOS activity and by the finding that Dexras1 activation
is diminished in the brains of mice harboring a targetedIntroduction
genomic deletion of nNOS (nNOS2/2). We also find that
nNOS, CAPON, and Dexras1 form a ternary complexNO serves multiple roles in biology, acting as the endo-
that enhances the ability of nNOS to activate Dexras1.thelial-derived relaxing factor in regulating blood vessel
These data identify a novel physiologic effector of NOrelaxation (Furchgott and Zawadzki, 1980; Ignarro et
in the brain and suggest that juxtaposition of nNOS andal., 1981, 1987; Palmer et al., 1987), enabling activated
its targets may be a mechanism by which NO signalingmacrophages to kill tumor cells and bacteria (Hibbs et
is enhanced.al., 1987; Stuehr et al., 1989), and serving as a neuro-
transmitter both in the brain and the peripheral nervous
system (Garthwaite et al., 1988; Bredt and Snyder, 1989; Results
Knowles et al., 1989). NO is formed by the enzyme NO
synthase (NOS), which oxidizes a guanidino nitrogen Identification and Cloning of Dexras1
To identify proteins that are associated with the PTBof arginine to NO with the stoichiometric formation of
citrulline. Three distinct forms of NOS exist, derived from domain of CAPON, we conducted a yeast two-hybrid
screen. A rat hippocampal/cortical cDNA library wasseparate genes and designated endothelial NOS (eNOS),
inducible or macrophage NOS (iNOS), and neuronal NOS screened against the CAPON PTB domain (amino acids
20–180), and a single transformant expressing residues(nNOS) (Griffith and Stuehr, 1995). nNOS is larger than
eNOS and iNOS because of an N-terminal extension 235–280 of rat Dexras1 was isolated (see Experimental
Procedures). A full-length cDNA of Dexras1 was clonedthat contains a PDZ domain (Cho et al., 1992; Ponting
and Phillips, 1995) that interacts with a variety of other from a rat brain cDNA library whose deduced protein
sequence is identical to that of mouse, except that gly-
cine 267 is replaced by a serine in the rat sequence.* To whom correspondence should be addressed (email: ssnyder@
Dexras1 was previously identified as a member of thebs.jhmi.edu).
† These authors contributed equally to this work. Ras family within the Ras superfamily of small GTPases,
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Table 1. Binding of CAPON to Dexras1 in the Yeast Two-Hybrid System
Bait Trap Histidine Prototrophy LacZ Activity
CAPON (aa 20–180) Dexras1 (aa 235–280) 1 1
Dexras1 (aa 235–280) CAPON (aa 20–180) 1 1
CAPON (aa 20–180) Dexras1 (aa 1–232) 2 2
CAPON (aa 379–503) Dexras1 (aa 235–280) 2 2
Cain Dexras1 (aa 235–280) 2 2
FKBP12 Dexras1 (aa 235–280) 2 2
with 26% sequence identity with H-Ras. Dexras1 is a and Snyder, 1990). Dexras1 is detected in the eluates
derived from wild-type mice but not from nNOS2/2 micemember of the Rap subfamily (Rap1, Rap1B, Rap2A,
and Rap2B) of the Ras family, with 34% identity with (Figure 1D), demonstrating that nNOS is associated with
Dexras1 in vivo. We explored the requirement of CAPONRap1B and 36% identity with Rap2B (Kemppainen and
Behrend, 1998). in this interaction using GST pulldown studies in trans-
fected HEK293 cell lysates. In cells expressing GST-
Dexras1, CAPON, and nNOS, precipitation of Dexras1CAPON and Dexras1 Interact In Vitro and In Vivo
with glutathione agarose leads to the coprecipitation ofTo establish the specificity of interactions between
nNOS and CAPON (Figure 1E). This complex requiresCAPON and Dexras1 in the two-hybrid screen, we exam-
CAPON, as precipitation of GST-Dexras1 fails to copre-ined several Dexras1 constructs (Table 1). The C termi-
cipitate nNOS in lysates derived from cells that werenus of Dexras1 interacts with the N-terminal PTB domain
not transfected with CAPON. Cells transfected with onlyof CAPON but not with the C-terminal domain of CAPON
CAPON and nNOS show no precipitation of CAPON or(amino acids 379–503) or with two control proteins, CAIN
nNOS utilizing glutathione beads. Thus, CAPON func-and FKBP-12. Additionally, the N terminus of Dexras1
tions as an adaptor linking nNOS to Dexras1.(amino acids 1–232) does not interact with the CAPON
PTB domain. These data establish the specificity in
yeast of the interaction between the CAPON PTB do- Distribution of Dexras1
main and the C terminus of Dexras1. Northern blot analysis in rat tissues shows prominent
We confirmed the specificity of the interaction of expression of Dexras1 mRNA in the brain, with some-
CAPON and Dexras1 in binding studies utilizing immobi- what lesser levels in the testes and still lower levels in
lized GST-Dexras1 incubated with transfected HEK293 the lung (Figure 2A). Negligible expression is evident in
cell lysates containing various hemagglutinin (HA)- heart, spleen, liver, skeleton muscle, and kidney. West-
tagged CAPON fusions. GST-Dexras1 binds specifically ern blot analysis similarly reveals major enrichment in
to both full-length CAPON and its PTB domain (Figure the brain (Figure 2B). A previous study of Dexras1 mRNA
1A). GST-Dexras1 fails to interact with the C-terminal expression in mouse showed more prominent expres-
nNOS binding domain of CAPON or with HA-FKBP-12 sion in kidney and heart, which may reflect rodent-spe-
(Figure 1A). We next compared the binding of HA- cific differences in Dexras1 mRNA expression (Kemp-
CAPON to GST-Dexras1 and GST-H-Ras. HA-CAPON painen and Behrend, 1998). Additionally, in the Northern
binds to GST-Dexras1 but not to GST-H-Ras (Figure blot analysis in mice (Kemppainen and Behrend, 1998),
1B). Additionally, we find that GST-Dexras1 is unable GAPDH mRNA levels appeared to be much less in brain
to bind to nNOS (Figure 1B). These results further sup- samples than in heart and kidney, suggesting that, fol-
port the notion that CAPON interacts specifically with lowing correction for RNA loading, levels of Dexras1
Dexras1. mRNA would be enriched in brain in mice as well.
To determine if CAPON and Dexras1 interact in intact Dexras1 contains a CAAX box, suggesting that it may
cells, we conducted immunoprecipitation studies in be prenylated. We examined the membrane association
brain lysates, utilizing an antibody to Dexras1 (Figure of Dexras1 and five other proteins in the Ras superfamily
1C). Immunoprecipitation of Dexras1 results in the co- (Figure 2C). Dexras1 is principally soluble, though a
precipitation of CAPON, whereas both preimmune se- small fraction is detectable in membrane fractions.
rum and an antibody to H-ras do not coprecipitate H-Ras, R-Ras, Rap2, and Rac1 are almost exclusively
CAPON. These studies demonstrate that CAPON and membrane associated, while Rab6 occurs both in solu-
Dexras1 form a physiologic complex in vivo. ble and membrane fractions. As CAPON, like Dexras1,
is largely soluble (Jaffrey et al., 1998), CAPON/Dexras1
complexes are likely to be cytoplasmic. In other experi-Dexras1, CAPON, and nNOS Form
a Ternary Complex ments, we assessed the subcellular localizations of
CAPON and Dexras1 in nNOS2/2 mice. We have foundBecause nNOS interacts with the C terminus of CAPON
and Dexras1 interacts with its N terminus, we suspected that these proteins exhibit similar localizations in
nNOS2/2 and wild-type mice, indicating that nNOS isthat CAPON may serve as an adaptor protein, linking
nNOS to Dexras1. To detect these ternary complexes, not the primary determinant of the localization of these
proteins (M. F., S. R. J., and S. H. S., unpublished data).we incubated the NOS affinity resin 29, 59 ADP sepharose
(Bredt and Snyder, 1990) with brain lysates derived from To identify neuronal pathways that might be regu-
lated by Dexras1, we mapped the cellular distributionwild-type and nNOS2/2 mice. nNOS was eluted from the
resin with 10 mM NADPH as described previously (Bredt of Dexras1 mRNA in the brain. In situ hybridization re-
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Figure 1. Dexras1 and CAPON Form a Com-
plex In Vitro and In Vivo
(A) In vitro binding of GST-Dexras1 and
CAPON. HEK293 cells were transfected with
plasmids expressing the indicated HA-
tagged CAPON constructs. Cell lysates were
incubated with the indicated immobilized
GST fusion protein, and specifically bound
proteins were determined by washing the
resin five times followed by elution in SDS-
PAGE sample buffer and detection of HA
fusion proteins by Western blotting with an
anti-HA antibody. Input (5% of the material
applied to resins) are included to demon-
strate the size of the different tagged pro-
teins.
(B) CAPON binds to GST-Dexras1 but not
GST-H-Ras. As in Figure 1A, HA-CAPON, HA-
NOS, and HA-FKBP12 were tested for their
ability to interact with the indicated GST fu-
sions.
(C) CAPON and Dexras1 exist as a physio-
logic complex in rat brain lysates. Dexras1
was immunoprecipitated from rat brain cyto-
sol with a rabbit anti-Dexras1 antibody bound
to protein A-agarose. CAPON was detected in these precipitates but not in the indicated control immunoprecipitates.
(D) Dexras1 and nNOS exist in a complex in vivo. Whole-brain cytosol fractions were prepared from wild-type and nNOS2/2 mice and incubated
with the nNOS affinity resin, 29, 59-ADP ribose sepharose. Both CAPON and Dexras1 were precipitated by the resin but only in cytosol
containing nNOS, not from cytosol prepared from nNOS2/2 mice. Input lanes containing 5% of the starting material show that Dexras1
expression is identical in wild-type and nNOS2/2 mice.
(E) CAPON is required for the formation of the ternary complex. Plasmids expressing nNOS, CAPON, and GST-Dexras1 were transfected into
HEK293 cells in the indicated combination, and GST-Dexras1 was precipitated by incubation of the cell lysates with glutathione agarose,
washed extensively, and bound nNOS and CAPON were detected by immunoblot. Dexras1 precipitated nNOS only in the presence of CAPON.
veals that Dexras1 is localized to discrete neuronal pop- and the Purkinje cell layer of the cerebellum (Figure 2D).
Dexras1 is also expressed in the dentate gyrus and CA1ulations, with highest densities in the cortex as well as
the accessory olfactory nucleus, supraoptic nucleus, and CA2 regions of the hippocampus, with lesser label-
Figure 2. Tissue and Subcellular Distribution
of Dexras1
(A) Dexras1 Northern blot. Dexras1 mRNA
was localized by Northern blot using a cDNA
probe corresponding to amino acids 235–280
of Dexras1.
(B) Dexras1 is enriched in brain. The indicated
tissue (50 mg) was subjected to SDS-PAGE
and immunoblotted for Dexras1.
(C) Dexras1 is a predominantly cytoplasmic
protein. Cytosol and membrane fractions were
prepared (see Experimental Procedures). Each
sample (50 mg) was separated by SDS-PAGE
and immunoblotted with Dexras1 and the in-
dicated G protein–specific antibodies.
(D) Dexras1, CAPON, and nNOS mRNA colo-
calize in several neuronal populations. Dexras1,
CAPON, and nNOS mRNA were localized
as described in Experimental Procedures.
Dexras1, CAPON, and nNOS are detected in
the cortex ([a], [b], and [c], respectively), ven-
tral accessory olfactory nucleus ([d], [e], and
[f], respectively), supraoptic nucleus ([g], [h],
and [i], respectively), and hippocampus ([j],
[k], and [l], respectively). The dentate gyrus
(DG) as well as the CA1, CA2, and CA3 por-
tions of the hippocampus are indicated. Mag-
nification: (a–f), 53; (g-i), 103; (j-l), 2.53.
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ing of the CA3 region (Figure 2D). Lower levels of
Dexras1 are detected in the thalamus, diagonal band
of Broca, and the substantia nigra, pars compacta.
Dexras1 also occurs in the pontine nucleus, the trape-
zoid body, the pedunculopontine tegmental nucleus,
and the nucleus solitarius (data not shown).
We next compared the distribution of Dexras1, CAPON,
and nNOS mRNAs. We find these mRNAs expressed in
many similar neuronal populations. The three mRNAs
are coexpressed in the cortex, although in scattered
cortical medium aspiny neurons nNOS is expressed at
Figure 3. Dexras1 Is S-Nitrosylated by NO Donorsan unusually high level, which is not the case for either
(A) GST-Dexras1 is S-nitrosylated by SNAP. GST-Dexras1 was pre-Dexras1 or CAPON. The three mRNAs are also coex-
incubated with 0.5 mM SNAP or NAP, desalted, and then subjectedpressed in the accessory olfactory nucleus and the su-
to the S-nitrosylation assay. After the S-nitrosylation assay, the sam-
praoptic nucleus (Figure 2D). All three mRNAs are ex- ples were resolved by SDS-PAGE and immunoblotted with an anti-
pressed in the hippocampus, with higher levels of mRNA biotin antibody. Only Dexras1 incubated with the NO donor was
in the CA1 and CA2 and with lower levels in CA3 (Figure capable of eliciting a signal in this assay.
(B) Dexras1 and H-ras are preferentially S-nitrosylated in GSNO-2D). In the dentate gyrus, nNOS mRNA is more promi-
treated brain lysates. Brain lysates were incubated with 40 mMnent than either CAPON or Dexras1. Several other re-
GSNO or GSH, and S-nitrosylated proteins were biotinylated usinggions, including the pontine nucleus, trapezoid body,
the S-nitrosylation assay and then purified on neutravidin-agarose
the pedunculopontine nucleus, and the nucleus solita- by 2-ME elution. 2-ME eluates were blotted with the indicated G
rius, also express all three mRNAs, albeit at a lower protein antibodies. Only Dexras1 and H-Ras were detected in 2-ME
level. eluates treated with NO donors. Input represents 0.2% of the mate-
rial applied to the neutravidin agarose.
Dexras1 Is S-Nitrosylated by NO Donors
Ras-like G proteins alternate between an “inactive”
2000). The biotinylated proteins were bound to neutravi-GDP-bound state and an “active” GTP-bound state
din agarose and then purified by cleavage of the disul-through the action of guanine-nucleotide exchange fac-
fide cross-linked biotin with 2-mercaptoethanol (2-ME).tors (GEFs), which enable GTP to bind by triggering the
The 2-ME eluates derived from lysates treated with GSHdissociation of GDP, and by GTPase-activating proteins,
exhibit no detectable G protein, while 2-ME eluates fromwhich increase the hydrolysis of GTP to GDP. In addition
lysates treated with GSNO contain detectable amountsto these mechanisms, H-Ras can also be activated by
of H-Ras and Dexras1 but not two other control G pro-S-nitrosylation, which leads to enhanced guanine-nucleo-
teins, Rab6 and Rap2 (Figure 3B). These findings indi-tide exchange activity and a resulting increase in the
cate that Dexras1 reacts with NO donors to form nitro-concentration of active GTP-bound H-Ras (Lander et
sothiol adducts and that incubation of tissue lysatesal., 1995). This effect is mediated by the nitrosothiol-
with NO donors leads to preferential nitrosylation ofmodified protein alone and does not require a separate
Dexras1 and H-Ras.GEF protein.
The 26% sequence identity between H-ras and
Dexras1 raised the possibility that Dexras1 may also Dexras1 Guanine-Nucleotide Exchange Activity
Is Activated by NO Donorsbe S-nitrosylated by NO. To determine if Dexras1 was
susceptible to S-nitrosylation, we incubated purified S-nitrosylation of H-ras by NO donors is associated with
enhanced guanine-nucleotide exchange activity. WeGST-Dexras1 with the NO donor SNAP or the control
compound NAP for 30 min and then isolated the protein compared the ability of an NO donor to activate Dexras1
and H-Ras (Figures 4A and 4B). S-nitroso-acetylpenicil-by spin column chromatography. Dexras1 in the eluate
was examined for the presence of nitrosothiol adducts lamine (SNAP) increases the dissociation of [3H]GDP
from Dexras1 and H-Ras to a similar extent, with a signif-using an S-nitrosylation assay in which S-nitrosocys-
teine residues are biotinylated and the biotinylated pro- icant effect evident at 1 mM and further increases at
higher concentrations of SNAP (Figure 4A). By contrast,teins are subsequently detected by immunoblotting with
an anti-biotin antibody (Jaffrey et al., 2000). Preincuba- N-acetylpenicillamine (NAP) has no effect at concentra-
tions as high as 1 mM, establishing that the effects oftion of GST-Dexras1 with SNAP leads to S-nitrosylation
of the protein (Figure 3A). The absence of a signal in SNAP are due to its NO moiety. In other experiments,
Dexras1 and H-Ras were first treated with unlabeledGST-Dexras1 preparations treated with NAP indicates
that the signal is dependent on the NO moiety of SNAP. GDP, followed by [35S]GTP-g-S to facilitate detection
of NO-stimulated guanine-nucleotide exchange. SNAPTo determine if NO donors preferentially S-nitrosylate
Dexras1 relative to other G proteins, we incubated tissue augments [35S]GTP-g-S binding to Dexras1 and H-Ras
with similar concentration–response characteristics (Fig-lysates with glutathione (GSH) or S-nitrosoglutathione
(GSNO). The latter compound is present in the brain at ure 4B). We find a similar dose–response effect on
Dexras1 guanine-nucleotide exchange activity in bothmicromolar concentrations and has been proposed to
be a physiologic carrier of NO for S-nitrosylation reac- these assays, using sodium nitroprusside as the NO
donor and potassium ferricyanide as the inactive controltions in the cytosol (Gaston et al., 1993; Kluge et al.,
1997). Tissue lysates treated with GSNO or GSH were (data not shown). These experiments show that Dexras1,
like H-Ras (Lander et al., 1995), can be activated bysubjected to the S-nitrosylation assay (Jaffrey et al.,
Dexras1 Coupled to nNOS via CAPON
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Figure 4. Dexras1 Is Activated by NO Donors
and Enzymatically Generated NO
(A) A NO donor stimulates GDP release from
Dexras1 and H-Ras to a similar extent.
GST-Dexras1 and GST-Ras, preloaded with
[3H]GDP, were treated with various amounts
of the NO donor SNAP or the control com-
pound NAP for 30 min at 308C, followed by
determination of bound [3H]GDP. The control
compound (NAP) did not induce [3H]GDP re-
lease. Experiments shown are the average of
three separate trials with standard error less
than 5% in each.
(B) A NO donor stimulates Dexras1 and H-Ras
activation as measured by [35S]GTP-g-S bind-
ing. In these assays, GST fusion proteins, pre-
loaded with 2 mM unlabeled GDP, were incu-
bated with the indicated concentration of
SNAP or NAP and [35S]GTP-g-S for 30 min,
followed by assay of bound [35S]GTP-g-S. Ex-
periments shown are the average of three
separate trials with standard error less than
5% in each.
(C) Transfection of nNOS leads to activation of Dexras1 in HEK293 cells. Cells were transfected with the indicated amounts of pcDNA3-nNOS
and 100 ng of pMyc-Dexras1 and then metabolically labeled with [32P]orthophosphate to label intracellular nucleotide pools. Myc-Dexras1
was immunoprecipitated, and bound GDP and GTP were detected by TLC. Transfection of nNOS leads to an increased amount of GTP bound
to Dexras1.
(D) Dexras1 activation by nNOS is NO dependent and cGMP independent. HEK293 cells were transfected with pMyc-Dexras1 and pcDNA3-
nNOS, as indicated. 8-Bromo-cGMP (5 mM) failed to mimic the effect of nNOS, and the guanylyl cyclase inhibitor ODQ (10 mM) failed to inhibit
nNOS-dependent activation of Dexras1. nNOS activation of Dexras1 was inhibited by 500 mM L-NAME, which could be reversed by adding
5 mM L-arginine.
different classes of NO donors and, like H-ras, this Dexras1 Is Regulated by NO and NMDA Receptor
Activation in Cortical Neuronsactivation involves increased guanine-nucleotide ex-
change. To identify mechanisms by which Dexras1 activity may
be regulated in neurons, we examined the GTP:GDP
ratio in Dexras1 immunoprecipitates derived from meta-nNOS Activates Dexras1 in a
bolically labeled cortical neurons. Dexras1 immunopre-cGMP-Independent Manner
cipitates derived from cortical neurons stimulated withTo determine whether NO generated from nNOS can
100 mM NMDA exhibit increased GTP loading, indicatingactivate Dexras1, we transfected HEK293 cells, which
that Dexras1, like H-ras, is activated by NMDA receptordo not contain endogenous Dexras1 (data not shown),
stimulation (Yun et al., 1998). Pretreatment of neuronswith a Dexras1 plasmid and with varying amounts of
with 10 mM MK-801 prevented NMDA-induced Dexras1an nNOS-expressing plasmid. Cells were metabolically
activation, indicating that the stimulatory effect of NMDAlabeled with [32P]orthophosphate to label nucleotide
on Dexras activity requires calcium flux through thepools, and Dexras1 was immunoprecipitated. Bound
NMDA receptor. As NMDA receptor stimulation is cou-nucleotides were resolved by TLC to measure the
pled to nNOS activation (Bredt and Snyder, 1989), weGTP:GDP ratio, as an increased ratio reflects activation.
tested whether the effect of NMDA was mediated bynNOS transfection leads to activation of Dexras1 in a
nNOS using L-NAME. Pretreatment of neurons with 500dose-dependent fashion (Figure 4C). nNOS transfection
mM L-NAME blocks NMDA-stimulated Dexras1 activa-has no effect in cells that are not cotransfected with the
tion, indicating that the stimulatory effect of NMDA onMyc-Dexras-expressing plasmid (data not shown). NO
Dexras1 function requires NO synthesis. Thus, Dexras1generation mediates the effect of nNOS, as the NOS
activation is coupled to NMDA receptor–dependent NOinhibitor L-nitroarginine methyl ester (L-NAME) abol-
synthesis.ishes Dexras1 activation, while L-arginine reverses the
effects of L-NAME (Figure 4D). A nNOS C415H mutant,
which lacks catalytic activity (Richards et al., 1996), does Dexras1 Guanine-Nucleotide Exchange Activity
Is Decreased in nNOS-/- Micenot activate Dexras1. To determine if Dexras1 activation
stems from the augmentation of cyclic GMP formation To determine whether Dexras1 is regulated by nNOS
in the intact organism, we utilized nNOS2/2 mice. Weby NO, we treated cells with 5 mM 8-bromo-cyclic GMP,
a nonhydrolyzable cGMP analog that fails to activate immunoprecipitated Dexras1, as well as five other
members of the Ras superfamily, from the brains of wild-Dexras1. Moreover, 10 mM ODQ (1H-[1,2,4]oxadia-
zolo[4,3-a]quinoxalin-1-one), a guanylyl cyclase inhibi- type and nNOS2/2 mice and monitored their guanine-
nucleotide exchange activity (Figure 5A). In these experi-tor (Garthwaite et al., 1995), does not affect the activa-
tion of Dexras1 by nNOS (Figure 4D). Thus, Dexras1 is ments, we assessed the guanine-nucleotide exchange
activity of the Ras proteins by measuring [35S]GTP-g-Sactivated by enzymatically generated NO in a cGMP-
independent manner. binding to proteins that had been preloaded with un-
Neuron
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Figure 6. CAPON Enhances nNOS-Dependent Activation of
Dexras1
pMyc-Dexras1 was cotransfected with a subthreshold quantity of
pcDNA3-nNOS as well as pHA-CAPON or with pHA-CAPON-PTB.
A total of 650 ng of DNA was transfected into each plate, using the
parent vector pRK5 as the balance. Cells were metabolically labeled
with [32P]orthophosphate, as in Figure 5C and 5D. Myc-Dexras1
was immunoprecipitated, and GTP:GDP ratios were determined by
phosphorimaging quantitation of TLC-separated bound nucleo-
tides. nNOS minimally activates Dexras1 alone, while the addition
of CAPON leads to a significant increase of nNOS-mediated Dexras1
activation. CAPON alone fails to activate Dexras1. Expression of
the CAPON PTB domain, which is capable of binding to Dexras1
but not nNOS, fails to alter nNOS-mediated activation of Dexras1.
Experiments shown were replicated three times with essentially
identical results.
Figure 5. Regulation of Dexras1 by nNOS in Cortical Neurons and
in Intact Animals G protein was immunoprecipitated from wild-type and
(A) Dexras1 is activated in a nNOS- and NMDA-dependent manner nNOS2/2 animals by loading immunoprecipitates with
in cortical neurons. Cortical neurons were metabolically labeled with
[35S]GTP-g-S. Levels of G proteins in the immunoprecipi-[32P]orthophosphate to label intracellular nucleotide pools and
tates were quantitated by scintillation counting and var-treated as indicated. Endogenous Dexras1 was immunoprecipi-
ied by less than 5% between wild-type and nNOS2/2tated, and bound GDP and GTP were detected by TLC. Treatment
of neurons with 100 mM NMDA leads to increased Dexras1 guanine- animals. The selective reduction in guanine-nucleotide
nucleotide exchange activity. Pretreatment of cortical neurons with exchange activity of Dexras1 derived from nNOS2/2
the NMDA receptor antagonist MK801 (10 mM) blocked this effect, mice demonstrates that Dexras1 activation is physiolog-
as did 500 mM L-NAME, indicating that NMDA receptor–dependent
ically determined by nNOS.activation of nNOS is required for the activation of Dexras1. Immuno-
precipitates using preimmune serum failed to precipitate a detect-
able amount of radiolabeled nucleotides (data not shown). CAPON Enhances nNOS Activation of Dexras1
(B) Dexras1 is regulated by nNOS in intact animals. To detect G
Dexras1 is noteworthy in that it is both activated byprotein activation, a [35S]GTP-g-S binding assay was used. The indi-
nNOS and physically coupled to nNOS. To determinecated G proteins were immunoprecipitated with specific antibodies
whether the ternary complex of nNOS, CAPON, andand preloaded with unlabeled GDP. Extra GDP was then removed,
and the immunoprecipitated proteins were incubated with [35S]GTP- Dexras1 plays a role in Dexras1 activation, we cotrans-
g-S for 30 min at 308C to detect guanine-nucleotide exchange. fected various combinations of Dexras1, nNOS, and
Dexras1 immunoprecipitated from wild-type mice exhibited nearly CAPON into HEK293 cells labeled with [32P]orthophos-
twice as much guanine-nucleotide exchange as Dexras1 immuno-
phate and monitored Dexras1 activation by quantitationprecipitated from nNOS2/2 mice. H-Ras guanine-nucleotide ex-
of bound guanine nucleotides in immunoprecipitateschange activity was identical in both wild-type and nNOS2/2 mice,
(Figure 6). Our experiments transfecting different amountsas were the guanine-nucleotide exchange activities of several other
control G proteins. The results shown are the average of at least of nNOS had established that detectable activation of
four separate trials. Statistical significance was determined by t test Dexras1 can occur following transfection with 100 ng
(p , 0.005). of the nNOS expression vector (Figure 4C). Cotransfec-
tion of 50 ng of the nNOS plasmid and pMyc-Dexras1
resulted in only a small amount of Dexras1 activa-labeled GDP and normalized the values to those found
in immunoprecipitates derived from wild-type mice. tion. However, the combination of nNOS, CAPON, and
Dexras1 reproducibly activates Dexras1 to levels higherDexras1 activation is reduced about 50% in nNOS2/2
brains (Figure 5A), while the activation of H-Ras, R-Ras, than those seen with cotransfection of 500 ng of the
nNOS-expressing plasmid with pMyc-Dexras1. CAPONRap2, Rac1, and Rab6 is unaffected by nNOS deletion.
Protein levels of the six Ras superfamily members tested transfection by itself does not lead to activation, ruling
out the possibility that CAPON is a Dexras1-specificare the same in nNOS2/2 and wild-type mouse brains
(Figure 5). We also confirmed that the same amount of GEF (Figure 6). Also, we cotransfected nNOS, Dexras1,
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and the PTB domain of CAPON, which can bind Dexras1
but not nNOS. This CAPON construct fails to activate
Dexras1 beyond the level seen with nNOS alone. Thus,
CAPON enhances nNOS-mediated activation of Dexras1
through the ternary complex whereby CAPON links
nNOS to Dexras1.
Discussion
In this study, we identify Dexras1 as a novel G protein
effector of nNOS. Dexras1 is S-nitrosylated by NO do-
nors, and Dexras1 is regulated by NMDA-dependent
NO production in cortical neurons. Dexras1 activity is
regulated by nNOS under basal physiologic condi-
Figure 7. Model of Dexras1 Activation by nNOStions, as Dexras1 activation is markedly diminished in
Dexras1, CAPON, and nNOS can form a complex that placesnNOS2/2 mice. This evidence that Dexras1 is a physio-
Dexras1 in proximity to CAPON. The most likely mechanismlogic target of basally generated NO is notable. Since
of Dexras1 activation is S-nitrosylation, which is likely to be highly
NO is a reactive free radical, its application affects a efficient due to the juxtaposition of nNOS and Dexras1. nNOS is a
wide range of proteins, such as H-ras, that have been dimer (not shown), and, conceivably, one monomer may bind to
proposed as physiologic targets. However, there are PSD95 and the other to CAPON/Dexras, thus allowing Dexras1 to
be activated by NMDA receptor–gated calcium.few examples of proteins whose activity differs in wild-
type animals and nNOS2/2 mice. A role for the physio-
logic linkage by CAPON of nNOS to Dexras1 is sug-
gested by our finding that NO-mediated activation of cal neurons (Yun et al., 1998). Although comparatively
large amounts of NO do activate H-Ras in transfectedDexras1 is markedly enhanced by CAPON. This implies
that NO signaling is regulated by protein–protein interac- HEK293 cells (M. F., S. R. J., and S. H. S., unpublished
data) as well as in other cell types (Lander et al., 1995),tions that juxtapose nNOS with its targets.
One of the remarkable aspects of Dexras1 activation the failure to see differences in H-ras activation between
wild-type and nNOS2/2 mice may derive from the higheris the selectivity of its regulation by nNOS, as five other
members of the Ras superfamily exhibited identical gua- levels of NO generated in those studies. It is possible
that substantial NO release, as occurs during vascularnine-nucleotide exchange activity in both wild-type and
nNOS2/2 mice. Importantly, H-ras, which can be regu- stroke, might produce sufficient NO to activate both
H-Ras and Dexras1 and their respective signalinglated by iNOS in HUVEC cells (Lander et al., 1995) and
by nNOS in PC12 cells (Teng et al., 1999) and primary pathways.
There has been little characterization of Dexras1, andcortical neurons (Yun et al., 1998), exhibited identical
activity in both wild-type and knockout mice. The selec- its downstream targets are not definitively established.
Members of the Rap subfamily of Ras-like G proteinstivity of nNOS-mediated activation of Dexras1 appears
to derive from Dexras1’s unique ability to interact with transmit growth factor signals to MAP kinase, signaling
cascades through B-Raf preferentially over A-Raf (Oht-CAPON/nNOS complexes through its extended C termi-
nus. This C-terminal 7 kDa extension results in a 31 kDa suka et al., 1996; York et al., 1998; Dugan et al., 1999).
Dexras1 may have similar effectors as other Rap sub-G protein that is substantially larger than most other
Ras superfamily members, which are typically 21–24 family members, since its effector loop (residues 53–61)
is 78% identical to the effector loop in Rap2b (residueskDa. No other G protein has a C-terminal domain with
sequence similarity to that found in Dexras1, suggesting 32–40). Indeed, in preliminary experiments, we have
transfected Dexras1 into HEK293 cells and detectedthat Dexras1 is the only Ras-like G protein capable of
interacting with the CAPON PTB domain. activation of MAP kinase activity, monitored by the
phosphorylation of myelin basic protein (data notDexras1 binds to the PTB domain located at the N
terminus of CAPON. The PTB domain of CAPON is most shown). Conceivably, Dexras1-specific effectors may
exist that mediate the effects of NO in the central ner-similar to the PTB domain of mouse Numb, which, like
CAPON, lacks certain residues that are expected to con- vous system.
Ras family members have been implicated in growthtact the phosphotyrosine, based on extrapolation from
the crystal structure of the Shc PTB domain (Zhou et and differentiation of neurons (Curtis and Finkbeiner,
1999). nNOS exhibits a dynamic cell-type specific pat-al., 1995). In the case of Numb, its protein targets lack
phosphotyrosine, as exemplified by Numb-associated tern of expression during development of the embryonic
brain (Bredt and Snyder, 1994), and neurons in nNOS2/2kinase (Chien et al., 1998) and LNX (Dho et al., 1998).
This also appears to be the case for the interaction of mice have impaired dendritic arborization (Inglis et al.,
1998). A role for NO in the differentiation of PC12 cellsDexras1 and CAPON, as we found that Dexras1 ex-
pressed in bacteria, which is not phosphorylated, ro- has also been established (Peunova and Enikolopov,
1995). It will be important to determine which of thesebustly binds CAPON, indicating that this interaction
does not require phosphotyrosine. NO-dependent functions are mediated by Dexras1.
S-nitrosylation is the most likely mechanism for NO-Several studies have shown that H-ras is regulated
by iNOS in HUVEC cells (Lander et al., 1995) and by dependent activation of Dexras1. This is likely as NO
donors directly S-nitrosylate Dexras1, and Dexras1 isnNOS in PC12 cells (Teng et al., 1999) and primary corti-
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sequentially in 23 SSC with 0.05% SDS four times at room tempera-preferentially S-nitrosylated over other similar G pro-
ture for 30 min and in 0.13 SSC with 0.1% SDS twice at 408C. Theteins. Secondly, S-nitrosylation is also associated with
blot was apposed to film using indirect autoradiography for 24 hrthe activation of H-ras (Lander et al., 1995, 1996; Mott
at 2708C.
et al., 1997), and mutagenesis of cysteine 118, the Tissues from an adult male rat were homogenized in ice-cold lysis
S-nitrosylated residue, in H-ras abolishes its sensitiv- buffer A (50 mM Tris-HCl [pH 7.7], 100 mM NaCl, 2 mM EDTA, 1
mM phenylmethylsulfonyl fluoride (PMSF), 5 mg/ml aprotinin, 1 mg/ity to NO (Lander et al., 1996). Although there is no
ml leupeptin, and 1 mg/ml pepstatin A). Cellular debris was removedcysteine in Dexras1 that corresponds to cysteine 118 in
by centrifugation at 800 3 g for 10 min at 48C, the supernatant wasH-Ras, several candidate cysteines can be identified by
centrifuged at 100,000 3 g for 20 min at 48C, and the supernatantthe presence of adjacent polar amino acids that corre-
was saved as “cytosol” fraction. Immunoblotting was performed
spond to a proposed consensus site for S-nitrosylation using a rabbit anti-Dexras1 antibody generated against the unique
(Stamler et al., 1997). C-terminal Dexras1 fragment isolated in the yeast two-hybrid screen
and purified on a resin consisting of cross-linked GST-Dexras1 pre-Although nNOS directly S-nitrosylates peptides (Mayer
pared with dimethylpimelimidate, as described for the anti-CAPONet al., 1998) and proteins (Stamler et al., 1992), there are
antibody (Jaffrey et al., 1998). To obtain the “membrane” fractionconceptual difficulties in invoking S-nitrosylation as a
of brain, the pellet from the above centrifugation was sonicated inphysiologic signaling mechanism for NO. One problem is
lysis buffer B (lysis buffer A adjusted to 0.1% Triton X-100), followed
the abundance of iron-containing proteins and cofactors by centrifugation at 100,000 3 g for 20 min at 48C.
that might interact nonselectively with NO. Moreover,
most cells contain very high levels of glutathione, about In Situ Hybridization
5 mM, which would be expected to compete with thiol In situ hybridization was performed essentially as described pre-
viously (Borjigin et al., 1999), with minor modifications. In brief, fresh-groups in proteins for binding NO. Juxtaposition of
frozen rat brain sections were fixed with 4% paraformaldehyde/PBSDexras1 and nNOS should increase the effective con-
and permeabilized, prehybridized, and hybridized in 50% for-centration of NO in the vicinity of Dexras1, making it a
mamide, 53 SSC with 100 ng/ml unhydrolyzed digoxygenin-labeledpreferred target for S-nitrosylation. The ternary complex
probe overnight at 558C (nNOS, CAPON) or 658C (Dexras). Sections
of nNOS, CAPON, and Dexras1 provides a system that were washed, blocked, and incubated overnight at 48C in 4% normal
is uniquely suited for targeting NO to protein targets for goat serum in TBS with antidigoxygenin-AP antibody (Boehringer)
at 1:5000. After washing in TBS, slides were developed with 1 mlS-nitrosylation (Figure 7).
of color development solution, containing 3.375 mg/ml nitroblueBy analogy with kinase signaling, where anchoring
tetrazolium, 3.5 mg/ml BCIP, and 0.24 mg/ml levamisole, in the dark.proteins such as AKAPs (A-kinase anchoring proteins)
The color reaction was allowed to run 4–8 hr at room temperature.contribute substantially to the specificity and rate of
The reaction was stopped in ddH2O, and the slides were sealed in
kinase signaling reactions (Colledge and Scott, 1999), Aquapolymount. Unique probes to CAPON, nNOS, and Dexras1
we speculate that nNOS may rely on CAPON and other were generated from cDNA corresponding to amino acids 20–180
of CAPON, the full open reading frame (ORF) sequences of nNOS,nNOS-associated proteins, such as PSD95/93 (Brenman
and the 39UTR sequences of Dexras1, respectively. Probes gener-et al., 1996), to facilitate reactions of NO with its targets.
ated against the Dexras1 ORF sequence and the Dexras1 39UTRInterestingly, the NMDA receptor, whose activity can be
generated identical results. Templates were generated by PCR, sub-modulated by NO donors (Choi et al., 2000), is coupled
cloned into pBS (Stratagene), and antisense and sense cRNA probes
to nNOS through a mutual interaction with PSD95 (Satt- were generated by T7 and T3 RNA polymerases. Sense control
ler et al., 1999). Conceivably, this anchoring of nNOS probes used at equal concentration generated no specific signal.
CAPON was localized to the supraoptic nucleus by immunohisto-may be required for the regulation of NMDA receptors
chemistry (Jaffrey et al., 1998).by NO in vivo.
Experimental Procedures Protein Binding Assays
GST fusion proteins were prepared as described previously (Jaffrey
General Methods and Materials et al., 1998). Transfections were performed with 10 mg or the indi-
Molecular biology reagents were from New England Biolabs (Bev- cated quantity of each plasmid, using the calcium phosphate
erly, MA). G protein antibodies were from Santa Cruz Biotechnology method. At 48 hr after transfection, cells were lysed in 1 ml lysis
(Santa Cruz, CA), SNAP was from RBI (Natick, MA), and NAP was buffer C (50 mM Tris-HCl [pH 7.4], 40 mM NaCl, 1 mM EDTA, 1%
from Aldrich Chem. Co. (Milwaukee, WI). All other reagents were Triton X-100, 1.5 mM NaVO4, 50 mM NaF, 10 mM sodium pyrophos-
from Sigma (St. Louis, MO), except as indicated. phate, 10 mM sodium b-glycerophosphate, 1 mM PMSF, 5 mg/ml
aprotinin, 1 mg/ml leupeptin, and 1 mg/ml pepstatin A) and cleared
by centrifugation. This cellular lysate was incubated with GST fusioncDNA Cloning and Localization of Rat Dexras1
The two-hybrid screens were done as described (Jaffrey et al., 1998). protein immobilized on glutathione agarose for 1 hr at 48C and
washed four times with washing buffer (lysis buffer C plus 300 mMThe PTB domain of rat CAPON, comprising amino acids 20–180,
was constructed by PCR and subcloned into the SalI and NotI sites NaCl). In GST pulldown assays, HEK293 cells transfected with pCIS-
GST-Dexras1 as well as the indicated plasmids were lysed in 0.5of pPC97, encoding a GAL4 BD-CAPON-PTB fusion protein. Other
control plasmids were also prepared by PCR and subcloned into ml lysis buffer C. GST agarose was incubated with clarified cell
lysates for 1 hr. After incubation, the resin was washed five timesSalI and NotI sites of either pPC86 or pPC97, as indicated. A total
of 2 3 106 independent clones were screened, and a positive clone with lysis buffer C adjusted to 250 mM NaCl, and bound proteins
were eluted by boiling in 13 SDS-PAGE sample buffer.carrying 330 bp cDNA was identified by selecting for histidine proto-
trophy and the presence of b-galactosidase activity, as described Immunoprecipitations were performed by homogenizing one rat
brain in 3 ml lysis buffer B, followed by centrifugation at 100,000 3previously (Jaffrey et al., 1998). The two-hybrid 330 bp Dexras1
fragment was used to screen a rat brain lamdaZAP II cDNA library g for 30 min at 48C. The supernatant (0.5 ml) was incubated with 40
ml of protein A-agarose (Calbiochem, La Jolla, CA) and 5 mg of the(Stratagene). A 1.6 kb full-length Dexras1 cDNA was isolated and
subcloned into pCMV for eukaryotic expression. indicated antibody for 60 min at 48C. The resins were then washed
with IP wash buffer (50 mM Tris-HCl [pH 7.7], 200 mM NaCl, and 2A commercial rat multiple tissue Northern blot (Clontech) was
hybridized in ExpressHyb solution (Clontech) at 688C for 1 hr with mM EDTA) three times and eluted in 30 ml of 13 SDS-PAGE sample
buffer by boiling. Detection of ternary complexes was done by incu-the 330 bp Dexras1 DNA probe labeled with [32P]CTP in a nick
translation system (Boehringer Mannheim). The blots were washed bating brain supernatants prepared from wild-type and nNOS2/2
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mice as above and then incubating with 100 ml 29, 59 ADP sepharose preloaded with 2 mM GDP in 200 ml of GDP loading buffer (20 mM
4B (Pharmacia) for 1 hr and then washing with IP wash buffer five Tris-HCl [pH 8.0], 10 mM EDTA, and 5 mM MgCl2). After incubation
times. Protein was eluted by incubation of the resin in 10 mM NADPH at 308C for 30 min, samples were washed three times with 500 ml
for 30 min. of reaction buffer (150 mM HEPES [pH 8.0], 180 mM MgCl2, 6 mM
EDTA, and 600 mM NaCl). The agarose beads were then resus-
pended in 50 ml of reaction buffer plus 3 mM GTP-g-S and 1 pmolS-Nitrosylation Assays
of [35S]GTP-g-S (1000 Ci/mmol) in the presence of different concen-Purified GST-Dexras1 in HEN buffer (250 mM HEPES [pH 7.7], 1 mM
trations of SNAP or NAP, as indicated in the figures. After incubationEDTA, and 0.1 mM neocuproine) (1 ng/ml) was incubated with the
at 308C for 30 min, samples were washed with 500 ml of the washingindicated concentrations of SNAP or NAP for 30 min at 258C in the
solution described above for three times. The agarose containingdark, and the NO donors were removed by desalting through a
[35S]GTP-g-S bound to GST fusion proteins were counted in a liquidMicroBioSpin6 column (Biorad). The S-nitrosylated protein was sub-
scintillation counter.jected to the S-nitrosylation assay as described elsewhere (Jaffrey
Immunoprecipitations for nucleotide exchange assays were per-et al., 2000). In brief, 75 ml of the flowthrough was blocked with
formed by homogenizing two brains from either wild-type ormethylmethanethiosulfonate (MMTS) blocking solution for 20 min
nNOS2/2 mice in 4 ml of lysis buffer D, followed by centrifugationat 508C, and, following removal of MMTS by desalting, S-nitrosylated
at 100,000 3 g for 20 min at 48C. Care was taken to rapidly homoge-cysteines were detected with biotin-HPDP (Pierce) and detected by
nize the tissue after decapitation to minimize postmortem NO pro-Western blotting with a biotin-specific antibody (Sigma). Detection
duction. The supernatant (0.5 ml) was incubated at 48C for 2 hr inof nitrosylated proteins in lysates incubated with GSNO was per-
the dark with 1 mg of the indicated antibody and 30 ml of protein-Aformed as described previously (Jaffrey et al., 2000). In brief, 750
agarose and then washed three times with 0.5 ml of lysis buffer Dmg of rat brain cortex was incubated with either 40 mM GSNO or
GSH for 20 min in the dark and subjected to the S-nitrosylation and once with GDP loading buffer. Samples were preloaded with
assay. Following the S-nitrosylation assay, biotinylated proteins GDP and incubated with [35S]GTP-g-S, as described above, except
were purified on neutravidin-agarose (Pierce) and then eluted with that no SNAP or NAP was added. After samples were washed three
2-mercaptoethanol and blotted with the indicated G protein–specific times with 0.5 ml of washing solution, the bound [35S]GTP-g-S was
antibody. counted as described above. Mice harboring a genomic deletion
of nNOS have been described previously (Huang et al., 1993) and
backcrossed a minimum of seven times against the C57/BL6 strain,Quantitation of Dexras1-Associated Nucleotides
which was the strain used for wild-type controls.GTP loading assays were performed as previously described (Rosen
et al., 1994). In brief, HEK293 cells were washed once with phos-
phate-free Dulbecco’s modified Eagle’s medium (GIBCO-BRL) be-
Acknowledgmentsfore incubation in the same medium plus 0.25 mCi/ml [32P]H3PO4 for
3 hr at 378C. Cortical neurons were prepared as described previously
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